CRISPR/FokI-dCAs9 technology generated an A to G change resulting in a glutamine to arginine substitution at amino acid 353. This mutation was identified in a large familial cohort with dilated cardiomyopathy. (J:335522)
查看原文 参与反馈
CRISPR/FokI-dCAs9 technology generated an A to G change resulting in a glutamine to arginine substitution at amino acid 353. This mutation was identified in a large familial cohort with dilated cardiomyopathy. (J:335522)